XinYi Biotech focuses on microdroplet technology and its applications across precision medicine, health management, and scientific research. The company develops microdroplet digital PCR systems and in vitro diagnostic (IVD) reagents and provides related products and services. It positions itself to offer high-quality products for clinical and research customers. Recently the company completed a B+ financing round of nearly RMB 100 million. Proceeds will fund clinical trials of its existing digital PCR products, R&D of innovative products, market promotion, and working capital. The company states its mission is to apply microdroplet technology to benefit medicine and scientific research.

Total raised

$14M

Funding rounds

1

Latest round

Series B

Latest activity

Feb 2024